Analysts Viewpoint Apellis Pharmaceuticals Inc (APLS) gets rating Downgrade from Raymond James Apellis Pharmaceuticals Inc’s recent filing unveils that its Former Officer Townsend Adam J. acquired Company’s shares for reported $3.92 million
Analysts Viewpoint Apellis Pharmaceuticals Inc [APLS] Investment Guide: What You Need to Know Apellis Pharmaceuticals Inc’s recently made public that its Former Officer Townsend Adam J. acquired Company’s shares for reported $3.92 million
Stock Earnings APLS Shares Experience Decline in Value Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Insiders Updates Apellis Pharmaceuticals Inc [APLS] Records 50-Day SMA of $22.67 Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals